4.8 Article

Inhibition of growth hormone signaling by the fasting-induced hormone FGF21

Journal

CELL METABOLISM
Volume 8, Issue 1, Pages 77-83

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2008.05.006

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCRR NIH HHS [P20 RR020691] Funding Source: Medline
  3. NIDCR NIH HHS [DE13686, R01 DE013686, R01 DE013686-08] Funding Source: Medline
  4. NIDDK NIH HHS [PL1 DK081182-01, PL1 DK081182, 1PL1DK081182-01] Funding Source: Medline
  5. NIGMS NIH HHS [RL1 GM084436-01, 1RL1GM084436-01, RL1 GM084436] Funding Source: Medline

Ask authors/readers for more resources

Starvation blocks the actions of growth hormone (GH) and inhibits growth through mechanisms that are not well understood. In this report, we demonstrate that fibroblast growth factor 21 (FGF21), a hormone induced by fasting, causes GH resistance. In liver, FGF21 reduces concentrations of the active form of signal transducer and activator of transcription 5 (STAT5), a major mediator of GH actions, and causes corresponding decreases in the expression of its target genes, including insulin-like growth factor 1 (IGF-1). FGF21 also induces hepatic expression of IGF-1 binding protein 1 and suppressor of cytokine signaling 2, which blunt GH signaling. Chronic exposure to FGF21 markedly inhibits growth in mice. These data suggest a central role for FGF21 in inhibiting growth as part of its broader role in inducing the adaptive response to starvation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available